March, 2012:

"Best-of" algorithm brings curation to Diabetes Nest

Sermo's new CEO vows to expand physician community

Company news: Astellas; AMM; MAHF; MedPage Today and Medscape Mobile

Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu

Company news: Merck, Affymax, AstraZeneca

CAHG-TBWA alliance will bring "disruption," says CEO

Company news: Bausch + Lomb and ISTA; Sanofi and Regeneron

Company news: Bausch + Lomb and ISTA; Sanofi and Regeneron

Millennium CEO says industry must brace for change

Social media an outcomes listening post for pharma

Diabetes study could create new class of surgical candidates

Obamacare reconsidered: a pretty good deal for the drug industry

Company news: Corcept Therapeutics and Daiichi Sankyo

Journal article targets FDA misstep on Aricept

Company news: GlaxoSmithKline, AstraZeneca, Nature Publishing

Guide to Interactive Companies

The pharma revolution will be digital, with new targets: study

Company news: Elsevier, Abbott

Study shows prescription gender gap

Sermo looks for new leaders—and profitability

People news: Harrison & Star, LLNS

GSK seeks to span digital divide with social/digital dragnet

Company news: Inventiv Health, Elsevier

Shire exits Fabry's market, citing costs as FDA weighs more research

Company news: GSK; J&J; CementBloc

Company news: Allergan, Pacific Communications and InVentiv

Study: sales support is dwindling, not dead

AstraZeneca's patent plight points toward takeover: analyst

Merz can't tout drug for wrinkles until 2013, judge rules

Company news: AstraZeneca and Edelman

FDA's 45-day TV ad review "shot clock" in guidance

Sharecare bulks up with RealAge buy

Company news: mobile ad budgets continue to grow

Facebook changes offer greater reach

Co-pay cards come under fire

Company news: Physicians Interactive, Boehringer Ingelheim

Judge puts freeze on Merz bid to challenge Botox

Company news: WebMD, Wiley-Blackwell and Eli Lilly/Boehringer Ingelheim

An FDA denial, but not the last word on Merck combo lipid drug

People moves: Alkermes and Euro RSCG Life UK

Lost in translation? International drug marketing guidelines are vague, toothless

Company news: GSK goes big in Japan

Endo rebrands to move beyond roots in pain drugs

GfK snags Bridgehead in bid to deepen payer expertise

Congress takes a stab at IPAB

People news: Novartis, Qforma and Precision Health Media

Komen Foundation nurses damaged brand

MM&M Awards 2012: How to Win an Award

State of Market Research: Analyze This

Specialty Pharma: Niches to Riches

Co-pay Cards: House of Cards

MAHF Inductees 2012: Heroes' Welcome

Headliner: Making tomorrow's portal personal

Desperate measures

Antidote: The problems facing Avastin

AstraZeneca to cut 7,300 more jobs

Solicitor General sides with reps in GSK overtime case

Study says docs favor COI disclosure

Success seen in fighting CME bias

Med Ed Report briefs—March 2012

Academics blast publishers' methods

Media Choice—March 2012

Professional Media briefs—March 2012

Do reviews have an evidence gap?

Coalition's gameplan for digital regs

P&G plans to cut its ad costs by shifting to digital media

Digital media briefs—March 2012

FDA study finds little harm in 'distracting visuals'

DDR on DTC: Toviaz vs. Vesicare

J&J names new OTC group chair

Vantage Point: How social media can make an impact

Market research kept out of Sunshine law

German firm accused of data breach

Merck respiratory goes to McCann

Dixon to lead MSL Group's measurement and analytics

Agency business briefs—March 2012

As I See It: Global systems for quality and safety

Sens. Klobuchar, Collins push drug-shortage bill

User-fee inaction could cause logjam

The very public risks of celebrity endorsements

Private View: Breaking the Healthcare Barriers

Upward Move: Chris Guiffre

People Moves: March 2012

Name That Brand—March 2012

CES: Convergence continues

Professional Marketing briefs—March 2012

Allergan scrubs some patient data

Checking 'sanity,' but not accuracy

At work with: Marsha Braverman